Aberrant mucosal lymphocyte number and subsets in the colon of post-infectious irritable bowel syndrome patients

References

• Quigley EM, Abdel-Hamid H, Barbara G, Bhatia SJ, Boeckxstaens G, De Giorgio R, et al. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol 2012;46:356–66.
   PubMed Web of Science ®Google Scholar
• Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009;136:1979–88.
   PubMed Web of Science ®Google Scholar
• Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804–11.
   PubMed Web of Science ®Google Scholar
• Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 2008;23:1689–94.
   PubMed Web of Science ®Google Scholar
• Sundin J, Rangel I, Fuentes S, de Vos W, Brummer RJ. Altered microbiota in the intestinal mucosa and faeces of PI-IBS patients. ESPEN 2013;13:Abstract 13-1400.
   Google Scholar
• Cheroutre H, Lambolez F, Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 2011;11:445–56.
   PubMed Web of Science ®Google Scholar
• Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol 2004;18:641–61.
   PubMed Web of Science ®Google Scholar
• Kumawat AK, Strid H, Elgbratt K, Tysk C, Bohr J, Hultgren Hörnquist E. Microscopic colitis patients have increased proportions of Ki67(+) proliferating and CD45RO(+) active/memory CD8(+) and CD4(+)8(+) mucosal T cells. J Crohns Colitis 2013;7:694–705.
   PubMed Web of Science ®Google Scholar
• De Vuyst L, Leroy F. Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. Int J Food Microbiol 2011;149:73–80.
   PubMed Web of Science ®Google Scholar
• Harrell L, Wang Y, Antonopoulos D, Young V, Lichtenstein L, Huang Y, et al. Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon. PLoS One 2012;7:e32545.
   PubMed Web of Science ®Google Scholar
• Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005;100:373–82.
   PubMed Web of Science ®Google Scholar
• Carroll IM, Chang YH, Park J, Sartor RB, Ringel Y. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog 2010;2:19.
   PubMed Web of Science ®Google Scholar
• van der Veek PP, van den Berg M, de Kroon YE, Verspaget HW, Masclee AA. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am J Gastroenterol 2005;100:2510–16.
   PubMed Web of Science ®Google Scholar
• Gunther U, Holloway JA, Gordon JN, Knight A, Chance V, Hanley NA, et al. Phenotypic characterization of CD3-7+ cells in developing human intestine and an analysis of their ability to differentiate into T cells. J Immunol 2005;174:5414–22.
   PubMedGoogle Scholar
• Martínez C, González-Castro A, Vicario M, Santos J. Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome. Gut Liver 2012;6:305–15.
   PubMedGoogle Scholar
• Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 2006;101:1288–94.
   PubMed Web of Science ®Google Scholar
• Zouali M, Richard Y, Marginal Zone B-Cells, a Gatekeeper of Innate Immunity. Front Immunol 2011;2:63–1–10.
   PubMed Web of Science ®Google Scholar
• Forshammar J, Isaksson S, Strid H, Stotzer PO, Sjövall H, Simrén M, et al. A pilot study of colonic B cell pattern in irritable bowel syndrome. Scand J Gastroenterol 2008;43:1461–6.
   PubMed Web of Science ®Google Scholar
• Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012;30:221–41.
   PubMed Web of Science ®Google Scholar
• Arce S, Luger E, Muehlinghaus G, Cassese G, Hauser A, Horst A, et al. CD38 low IgG-secreting cells are precursors of various CD38 high-expressing plasma cell populations. J Leukoc Biol 2004;75:1022–8.
   PubMedGoogle Scholar
• Parel Y, Aurrand-Lions M, Scheja A, Dayer JM, Roosnek E, Chizzolini C. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum 2007;56:3459–67.
   PubMed Web of Science ®Google Scholar
• Rocha B. The extrathymic T-cell differentiation in the murine gut. Immunol Rev 2007;215:166–77.
   PubMed Web of Science ®Google Scholar
• Pahar B, Lackner AA, Veazey RS. Intestinal double-positive CD4+CD8+ T cells are highly activated memory cells with an increased capacity to produce cytokines. Eur J Immunol 2006;36:583–92.
   PubMed Web of Science ®Google Scholar
• Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, et al. The immune system in extreme longevity. Exp Gerontol 2008;61–5.
   PubMedGoogle Scholar
• Dunlop SP, Jenkins D, Neal KR, Naesdal J, Borgaonker M, Collins SM, et al. Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2003;18:77–84.
   PubMed Web of Science ®Google Scholar